Pure Global
NCT06227611

Evaluation of Different Perimetric Grids to Detect Central Visual Field Defect in Glaucoma Patients With Reduce Ganglion Cell Layer Thickness Measured by Spectral Domain OCT.

Fondazione G.B. Bietti, IRCCS·ClinicalTrials.govRecruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Glaucoma
Study type
Observational
Sponsor & location
Primary sponsor
Fondazione G.B. Bietti, IRCCS
Location
Rome,Rome, Italy
Timeline & enrollment
Phase
N/A
Start date
May 04, 2021
End date
May 04, 2025
Enrollment
16 participants
Primary outcome

the agreement between 10-2 HFA and 24-2c HFA in detecting central visual field defect

Summary

The aim of the study is to evaluate the agreement between three different grids in detecting
 central visual field defect in early glaucoma patients with reduced ganglion cell layer
 thickness.

ICD-10 classifications
GlaucomaGlaucomaOther glaucomaGlaucoma, unspecifiedGlaucoma in diseases classified elsewhere
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06227611
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06227611 through Pure Global AI's free database. This phase not specified trial is sponsored by Fondazione G.B. Bietti, IRCCS and is currently Recruiting. The study focuses on Glaucoma. Target enrollment is 16 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.